LiveITC associates with NITI Aayog to train 2 lakh farmers
ITC has associated with NITI Aayog to train 2 lakh farmers, to increase their income and raise productivity of major crops. This association is for 25...
Category : Latest News
Lodha Group files draft papers for IPO
The Lodha Group has filed the draft red herring prospectus for issue, and is planing to raise more than Rs.5,000 crore via an IPO. The...
Essel Propack recommends bonus issue in the ratio of 1:1
Essel Propack in its meeting held on April 26, has recommended bonus issue of equity shares in the ratio of 1:1. This means 1 equity...
Thermax bags order worth Rs.279 crore
Thermax Group has bagged an order worth Rs.279 crore, to set up a captive cogeneration plant at Trombay, from a leading public sector fertilizer company. The...
Belgium based AnSem N V acquired by Cyient
Cyient Limited‘s step down subsidiary Cyient Europe Ltd. has acquired Belgium-based AnSem N V. AnSem N V is a leading fabless, analog application-specific integrated circuits (ASICs)...
Biocon reports marginal growth of 2% in net profit for Q4
Biocon has reported approx 2% growth in its net profit at Rs.130 crore, for the quarter ended March 31,2018. The company in the same quarter last...
Axis Bank reports Q4 loss at Rs.2,189 crore
Axis Bank has reported a loss of Rs.2,188.74 crore, for the quarter ended March 31. 2018. Last year in the same quarter it had posted...
Ford launches Freestyle priced at Rs.5.09 lakh
Ford India has launched Freestyle, an upgraded version of the Figo in the premium hatchback segment, priced at Rs.5.09 lakh (base petrol version, ex-showroom). The...
N K Sahu ex-RBI official appointed as Religare’s group head–compliance
Religare Enterprises Limited (REL) has appointed Nitya Kishore Sahu as group head–compliance. The company stated, “He will be responsible for spearheading group-wide compliance function. His...
Indoco Remedies receives non-compliance statement form UK-MHRA
Indoco Remedies has received statement for non compliance and restricted GMP certificate, to allow continued manufacture and testing of products considered to be medically critical or...